The current study focuses on differentiating the contribution of CCL2-CCR2 interaction within CCR2+ BM-derived CD11b+Gr1+ cells from the autocrine effect of CCL2 on CCR2 expressed by the cancer cells. Here, CCL2 is linked to cancer.